tradingkey.logo

Bayer AG Announces US FDA Approved KERENDIA

ReutersJul 14, 2025 6:55 AM

- Bayer AG BAYGn.DE:

  • BAYER AG: US FDA APPROVED KERENDIA TO TREAT PATIENTS WITH HEART FAILURE WITH LEFT VENTRICULAR EJECTION FRACTION ≥40%

Further company coverage: [BAYGn.DE]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI